Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Hi-Tech Pharmacal, a specialty pharmaceutical company, has announced that the FDA granted final approval to the company's abbreviated new drug application for dorzolamide ophthalmic solution, 2%.
Subscribe to our email newsletter
Hi-Tech’s dorzolamide ophthalmic solution is the generic for Merck’s Trusopt ophthalmic solution 2%, indicated for elevated intraocular pressure in patients with ocular hypertension or open-angel glaucoma.
Hi-Tech said that it plans to launch generic dorzolamide ophthalmic solution 2% immediately.